(S)-adrenaline; 150-05-0; (+)-adrenaline; (+)-epinephrine; Racepinefrine, (S)-; 4-[(1S)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol; d-Adrenaline; D-Epinephrine; (S)-(+)-adrenaline; 1,2-Benzenediol, 4-[(1S)-1-hydroxy-2-(methylamino)ethyl]-; NA71GR3TNV; CHEMBL42280; CHEBI:40751; L-(+)-Adrenaline; 2-hydroxy-4-[1-hydroxy-2-(methylazaniumyl)ethyl]phenolate; Vaponefrin; Adrenan; Epitrate; Adrine; (S)-4-(1-Hydroxy-2-(methylamino)ethyl)pyrocatechol; D-Epifrin; (S)-4-[1-HYDROXY-2-(METHYLAMINO)ETHYL]PYROCATECHOL; D-(+)-Epinephrine; BRN 2938799; UNII-NA71GR3TNV; NSC62786; 1-Epirenamine; 1,2-BENZENEDIOL, 4-((1S)-1-HYDROXY-2-(METHYLAMINO)ETHYL)-; 1-Adrenaline; (S)-racepinefrine; EINECS 205-752-5; EPINEPHRINE, D-; D(+)-ADRENALINE; 3,4-Dihydroxy-.alpha.-[(methylamino)methyl]benzyl alcohol; SCHEMBL11647; 2-13-00-00525 (Beilstein Handbook Reference); GTPL4450; (+)-(S)-EPINEPHRINE; UCTWMZQNUQWSLP-SECBINFHSA-; ZINC39090; 4-[(1R)-1-hydroxy-2-methylamino-ethyl]benzene-1,2-diol; WLN: QR BQ DYQ1M1 -L; DTXSID301047668; 1,2-Benzenediol, 4-(1-hydroxy-2-(methylamino)ethyl)-, (S)-; IOP; BDBM50087512; AKOS006271962; BENZYL ALCOHOL, 3,4-DIHYDROXY-alpha-((METHYLAMINO)METHYL)-, (+)-; SDCCGMLS-0066643.P001; NCGC00178888-01; AS-77747; SBI-0051363.P003; D95540; AB00053471_02; 1, 4-[1-hydroxy-2-(methylamino)ethyl]-, (R)-; Q27074317; 4-[(1S)-1-hydroxy-2-methylaminoethyl]benzene-1,2-diol; Z1198154207; (+)-1-(3,4-DIHYDROXYPHENYL)-2-METHYLAMINOETHANOL; (+)-3,4-dihydroxy-alpha-((methylamino)methyl)benzyl alcohol; 4-((1S)-1-HYDROXY-2-(METHYLAMINO)ETHYL)-1,2-BENZENEDIOL; Benzyl alcohol,4-dihydroxy-.alpha.-[(methylamino)methyl]-, (-)-; BENZYL ALCOHOL, 3,4-DIHYDROXY-.ALPHA.-((METHYLAMINO)METHYL)-, (+)-; XDE